{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:08:55Z","timestamp":1792642135113,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,6,27]],"date-time":"2007-06-27T00:00:00Z","timestamp":1182902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1007\/s11899-007-0020-4","type":"journal-article","created":{"date-parts":[[2007,6,26]],"date-time":"2007-06-26T00:42:55Z","timestamp":1182818575000},"page":"143-150","source":"Crossref","is-referenced-by-count":11,"title":["Late effects of therapy for Hodgkin\u2019s lymphoma"],"prefix":"10.1007","volume":"2","author":[{"given":"Michael Jacob","family":"Adams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis S.","family":"Constine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Lipshultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,6,27]]},"reference":[{"key":"20_CR1","volume-title":"SEER Cancer Statistics Review, 1973\u20132001","author":"L.A.G. Ries","year":"2004","unstructured":"Ries LAG, Eisner MP, Kosary C, et al.: SEER Cancer Statistics Review, 1973\u20132001. Bethesda, MD: National Cancer Institute; 2004."},{"key":"20_CR2","first-page":"33","volume":"1","author":"P. Mauch","year":"1995","unstructured":"Mauch P, Kalish LA, Marcus KC, et al.: Long-term survival in Hodgkin\u2019s disease: relative impact of mortality, second tumors, infection, and cardiovascular disease. Cancer J Sci Am 1995, 1:33\u201342.","journal-title":"Cancer J Sci Am"},{"key":"20_CR3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1200\/JCO.2000.18.3.487","volume":"18","author":"F.E. Leeuwen van","year":"2000","unstructured":"van Leeuwen FE, Klokman WJ, Veer MB, et al.: Long-term risk of second malignancy in survivors of Hodgkin\u2019s disease treated during adolescence or young adulthood. J Clin Oncol 2000, 18:487\u2013497.","journal-title":"J Clin Oncol"},{"key":"20_CR4","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1200\/JCO.2003.11.059","volume":"21","author":"S. Bhatia","year":"2003","unstructured":"Bhatia S, Yasui Y, Robison LL, et al.: High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin\u2019s disease: report from the Late Effects Study Group. J Clin Oncol 2003, 21:4386\u20134394.","journal-title":"J Clin Oncol"},{"key":"20_CR5","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2002-02-0634","volume":"100","author":"A.K. Ng","year":"2002","unstructured":"Ng AK, Bernardo MV, Weller E, et al.: Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood 2002, 100:1989\u20131996.","journal-title":"Blood"},{"key":"20_CR6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.coc.0000045853.73233.42","volume":"27","author":"G.M. Chronowski","year":"2004","unstructured":"Chronowski GM, Wilder RB, Levy LB, et al.: Second malignancies after chemotherapy and radiotherapy for Hodgkin disease. Am J Clin Oncol 2004, 27:73\u201380.","journal-title":"Am J Clin Oncol"},{"key":"20_CR7","doi-asserted-by":"crossref","unstructured":"Dores GM, Metayer C, Curtis RE, et al.: Second malignant neoplasms among long-term survivors of Hodgkin\u2019s disease: a population-based evaluation over 25 years. J Clin Oncol 2002, 3484\u20133494.","DOI":"10.1200\/JCO.2002.09.038"},{"key":"20_CR8","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/jnci\/95.13.971","volume":"95","author":"F.E. Leeuwen van","year":"2003","unstructured":"van Leeuwen FE, Klokman WJ, Stovall M, et al.: Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin\u2019s disease. J Natl Cancer Inst 2003, 95:971\u2013980.","journal-title":"J Natl Cancer Inst"},{"key":"20_CR9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/jnci\/94.3.182","volume":"94","author":"L.B. Travis","year":"2002","unstructured":"Travis LB, Gospodarowicz M, Curtis RE, et al.: Lung cancer following chemotherapy and radiotherapy for Hodgkin\u2019s disease. J Natl Cancer Inst 2002, 94:182\u2013192.","journal-title":"J Natl Cancer Inst"},{"key":"20_CR10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jnci\/85.1.25","volume":"85","author":"S.L. Hancock","year":"1993","unstructured":"Hancock SL, Tucker MA, Hoppe RT: Breast cancer after treatment of Hodgkin\u2019s disease. J Natl Cancer Inst 1993, 85:25\u201331.","journal-title":"J Natl Cancer Inst"},{"key":"20_CR11","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJM199603213341201","volume":"334","author":"S. Bhatia","year":"1996","unstructured":"Bhatia S, Robison LL, Oberlin O, et al.: Breast cancer and other second neoplasms after childhood Hodgkin\u2019s disease. N Engl J Med 1996, 334:745\u2013751.","journal-title":"N Engl J Med"},{"key":"20_CR12","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/jnci\/dji290","volume":"97","author":"L.B. Travis","year":"2005","unstructured":"Travis LB, Hill D, Dores GM, et al.: Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst 2005, 97:1428\u20131437.","journal-title":"J Natl Cancer Inst"},{"key":"20_CR13","doi-asserted-by":"crossref","first-page":"590","DOI":"10.7326\/0003-4819-141-8-200410190-00006","volume":"141","author":"L.B. Kenney","year":"2004","unstructured":"Kenney LB, Yasui Y, Inskip PD, et al.: Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med 2004, 141:590\u2013597.","journal-title":"Ann Intern Med"},{"key":"20_CR14","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/(SICI)1097-0142(19970315)79:6<1203::AID-CNCR20>3.0.CO;2-2","volume":"79","author":"A.C. Aisenberg","year":"1997","unstructured":"Aisenberg AC, Finkelstein DM, Doppke KP, et al.: High risk of breast carcinoma after irradiation of young women with Hodgkin\u2019s disease. Cancer 1997, 79:1203\u20131210.","journal-title":"Cancer"},{"key":"20_CR15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jama.290.4.465","volume":"290","author":"L.B. Travis","year":"2003","unstructured":"Travis LB, Hill DA, Dores GM, et al.: Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 2003, 290:465\u2013475.","journal-title":"JAMA"},{"key":"20_CR16","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1182\/blood-2005-04-1535","volume":"106","author":"D.A. Hill","year":"2005","unstructured":"Hill DA, Gilbert E, Dores GM, et al.: Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors. Blood 2005, 106:3358\u20133365.","journal-title":"Blood"},{"key":"20_CR17","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/bjc.1995.359","volume":"72","author":"G. Albrektsen","year":"1995","unstructured":"Albrektsen G, Heuch I, Kvale G: The short-term and long-term effect of a pregnancy on breast cancer risk: a prospective study of 802,457 parous Norwegian women. Br J Cancer 1995, 72:480\u2013484.","journal-title":"Br J Cancer"},{"key":"20_CR18","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/pbc.20352","volume":"44","author":"M.J. Adams","year":"2005","unstructured":"Adams MJ, Lipshultz SE: Pathophysiology of anthracycline-and radiation-associated cardiomyopathies: implications for screening and prevention. Pediatr Blood Cancer 2005, 44:600\u2013606.","journal-title":"Pediatr Blood Cancer"},{"key":"20_CR19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1053-4296(96)80018-X","volume":"6","author":"S.L. Hancock","year":"1996","unstructured":"Hancock SL, Hoppe RT: Long-term complications of treatment and causes of mortality after Hodgkin\u2019s disease. Semin Radiat Oncol 1996, 6:225\u2013242.","journal-title":"Semin Radiat Oncol"},{"key":"20_CR20","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2003.07.131","volume":"21","author":"B.M. Aleman","year":"2003","unstructured":"Aleman BM, van den Belt-Dusebout AW, Klokman WJ, et al.: Long-term cause-specific mortality of patients treated for Hodgkin\u2019s disease. J Clin Oncol 2003, 21:3431\u20133439.","journal-title":"J Clin Oncol"},{"key":"20_CR21","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1182\/blood-2006-07-034405","volume":"109","author":"B.M. Aleman","year":"2007","unstructured":"Aleman BM, van den Belt-Dusebout AW, De Bruin ML, et al.: Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 2007, 109:1878\u20131886.","journal-title":"Blood"},{"key":"20_CR22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0360-3016(00)00647-7","volume":"48","author":"C.K. Lee","year":"2000","unstructured":"Lee CK, Aeppli D, Nierengarten ME: The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin\u2019s disease: University of Minnesota experience. Int J Radiat Oncol Biol Phys 2000, 48:169\u2013179.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"20_CR23","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1001\/jama.1993.03510160067031","volume":"270","author":"S.L. Hancock","year":"1993","unstructured":"Hancock SL, Tucker MA, Hoppe RT: Factors affecting late mortality from heart disease after treatment of Hodgkin\u2019s disease. JAMA 1993, 270:1949\u20131955.","journal-title":"JAMA"},{"key":"20_CR24","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1200\/JCO.1993.11.7.1208","volume":"11","author":"S.L. Hancock","year":"1993","unstructured":"Hancock SL, Donaldson SS, Hoppe RT: Cardiac disease following treatment of Hodgkin\u2019s disease in children and adolescents. J Clin Oncol 1993, 11:1208\u20131215.","journal-title":"J Clin Oncol"},{"key":"20_CR25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0167-8140(99)00026-2","volume":"51","author":"J.G. Reinders","year":"1999","unstructured":"Reinders JG, Heijmen BJ, Olofsen-van Acht MJ, et al.: Ischemic heart disease after mantlefield irradiation for Hodgkin\u2019s disease in long-term follow-up. Radiother Oncol 1999, 51:35\u201342.","journal-title":"Radiother Oncol"},{"key":"20_CR26","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/cncr.2820690528","volume":"69","author":"J.-F. Boivin","year":"1992","unstructured":"Boivin J-F, Hutchison G, Lubin J, Mauch P: Coronary artery disease mortality in patients treated for Hodgkin\u2019s disease. Cancer 1992, 69:1241\u20131247.","journal-title":"Cancer"},{"key":"20_CR27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1200\/JCO.2006.07.0805","volume":"25","author":"P.A. Heidenreich","year":"2007","unstructured":"Heidenreich PA, Schnittger I, Strauss HW, et al.: Screening for coronary artery disease after mediastinal irradiation for Hodgkin\u2019s disease. J Clin Oncol 2007, 25:43\u201349.","journal-title":"J Clin Oncol"},{"key":"20_CR28","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1200\/JCO.2004.09.109","volume":"22","author":"M.J. Adams","year":"2004","unstructured":"Adams MJ, Lipsitz SR, Colan SD, et al.: Cardiovascular status in long-term survivors of Hodgkin\u2019s disease treated with chest radiotherapy. J Clin Oncol 2004, 22:3139\u20133148.","journal-title":"J Clin Oncol"},{"key":"20_CR29","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.ahj.2004.12.026","volume":"150","author":"P.A. Heidenreich","year":"2005","unstructured":"Heidenreich PA, Hancock SL, Vagelos RH, et al.: Diastolic dysfunction after mediastinal irradiation. Am Heart J 2005, 150:977\u2013982.","journal-title":"Am Heart J"},{"key":"20_CR30","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/pbc.20213","volume":"45","author":"D. Iarussi","year":"2005","unstructured":"Iarussi D, Pisacane C, Indolfi P, et al.: Evaluation of left ventricular function in long-term survivors of childhood Hodgkin disease. Pediatr Blood Cancer 2005, 45:700\u2013705.","journal-title":"Pediatr Blood Cancer"},{"key":"20_CR31","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jnci\/djk029","volume":"99","author":"A.J. Swerdlow","year":"2007","unstructured":"Swerdlow AJ, Higgins CD, Smith P, et al.: Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst 2007, 99:206\u2013214.","journal-title":"J Natl Cancer Inst"},{"key":"20_CR32","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1200\/JCO.2005.15.107","volume":"23","author":"D.C. Bowers","year":"2005","unstructured":"Bowers DC, McNeil DE, Liu Y, et al.: Stroke as a late treatment effect of Hodgkin\u2019s disease: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2005, 23:6508\u20136515.","journal-title":"J Clin Oncol"},{"key":"20_CR33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/030089160609200406","volume":"92","author":"F. Bilora","year":"2006","unstructured":"Bilora F, Pietrogrande F, Petrobelli F, et al.: Is radiation a risk factor for atherosclerosis? An echo-color Doppler study on Hodgkin and non-Hodgkin patients. Tumori 2006, 92:295\u2013298.","journal-title":"Tumori"},{"key":"20_CR34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1200\/JCO.1994.12.2.297","volume":"12","author":"S.J. Horning","year":"1994","unstructured":"Horning SJ, Adhikari A, Rizk N, et al.: Effect of treatment for Hodgkin\u2019s disease on pulmonary function: results of a prospective study. J Clin Oncol 1994, 12:297\u2013305.","journal-title":"J Clin Oncol"},{"key":"20_CR35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.6004\/jnccn.2006.0024","volume":"4","author":"D.L. Friedman","year":"2006","unstructured":"Friedman DL, Constine LS: Late effects of treatment for Hodgkin lymphoma. J Natl Comp Cancer Netw 2006, 4:249\u2013257.","journal-title":"J Natl Comp Cancer Netw"},{"key":"20_CR36","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1200\/JCO.2005.02.7243","volume":"23","author":"W.G. Martin","year":"2005","unstructured":"Martin WG, Ristow KM, Habermann TM, et al.: Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin\u2019s lymphoma. J Clin Oncol 2005, 23:7614\u20137620.","journal-title":"J Clin Oncol"},{"key":"20_CR37","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1200\/JCO.2001.19.13.3226","volume":"19","author":"H. Knobel","year":"2001","unstructured":"Knobel H, Havard LJ, Brit LM, et al.: Late medical complications and fatigue in Hodgkin\u2019s disease survivors. J Clin Oncol 2001, 19:3226\u20133233.","journal-title":"J Clin Oncol"},{"key":"20_CR38","first-page":"3227","volume":"85","author":"C. Sklar","year":"2000","unstructured":"Sklar C, Whitton J, Mertens A, et al.: Abnormalities of the thyroid in survivors of Hodgkin\u2019s disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2000, 85:3227\u20133232.","journal-title":"J Clin Endocrinol Metab"},{"key":"20_CR39","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1200\/JCO.2005.05.0195","volume":"24","author":"M.L. Metzger","year":"2006","unstructured":"Metzger ML, Hudson MM, Somes GW, et al.: White race as a risk factor for hypothyroidism after treatment for pediatric Hodgkin\u2019s lymphoma. J Clin Oncol 2006, 24:1516\u20131521.","journal-title":"J Clin Oncol"},{"key":"20_CR40","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/jnci\/djj243","volume":"98","author":"C.A. Sklar","year":"2006","unstructured":"Sklar CA, Mertens AC, Mitby P, et al.: Premature menopause in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2006, 98:890\u2013896.","journal-title":"J Natl Cancer Inst"},{"key":"20_CR41","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1210\/jc.2006-0020","volume":"91","author":"W. Chemaitilly","year":"2006","unstructured":"Chemaitilly W, Mertens AC, Mitby P, et al.: Acute ovarian failure in the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2006, 91:1723\u20131728.","journal-title":"J Clin Endocrinol Metab"},{"key":"20_CR42","doi-asserted-by":"crossref","first-page":"7555","DOI":"10.1200\/JCO.2005.08.138","volume":"23","author":"K. Behringer","year":"2005","unstructured":"Behringer K, Breuer K, Reineke T, et al.: Secondary amenorrhea after Hodgkin\u2019s lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin\u2019s Lymphoma Study Group. J Clin Oncol 2005, 23:7555\u20137564.","journal-title":"J Clin Oncol"},{"key":"20_CR43","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1200\/JCO.1999.17.1.253","volume":"17","author":"J.H. Loge","year":"1999","unstructured":"Loge JH, Abrahamsen AF, Ekeberg O, Kaasa S: Hodgkin\u2019s disease survivors more fatigued than the general population. J Clin Oncol 1999, 17:253\u2013261.","journal-title":"J Clin Oncol"},{"key":"20_CR44","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.ejca.2006.08.006","volume":"42","author":"F. Mols","year":"2006","unstructured":"Mols F, Vingerhoets AJ, Coebergh JW, et al.: Better quality of life among 10\u201315 year survivors of Hodgkin\u2019s lymphoma compared to 5\u20139 year survivors: a population-based study. Eur J Cancer 2006, 42:2794\u20132801.","journal-title":"Eur J Cancer"},{"key":"20_CR45","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1200\/JCO.2005.09.936","volume":"23","author":"M.J. Hjermstad","year":"2005","unstructured":"Hjermstad MJ, Fossa SD, Oldervoll L, et al.: Fatigue in long-term Hodgkin\u2019s disease survivors: a follow-up study. J Clin Oncol 2005, 23:6587\u20136595.","journal-title":"J Clin Oncol"},{"key":"20_CR46","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ejca.2005.09.028","volume":"42","author":"M.J. Hjermstad","year":"2006","unstructured":"Hjermstad MJ, Oldervoll L, Fossa SD, et al.: Quality of life in long-term Hodgkin\u2019s disease survivors with chronic fatigue. Eur J Cancer 2006, 42:327\u2013333.","journal-title":"Eur J Cancer"},{"key":"20_CR47","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/annonc\/mdi407","volume":"16","author":"A.K. Ng","year":"2005","unstructured":"Ng AK, Li S, Recklitis C, et al.: A comparison between long-term survivors of Hodgkin\u2019s disease and their siblings on fatigue level and factors predicting for increased fatigue. Ann Oncol 2005, 16:1949\u20131955.","journal-title":"Ann Oncol"},{"key":"20_CR48","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1200\/JCO.2006.08.4772","volume":"25","author":"S.S. Donaldson","year":"2007","unstructured":"Donaldson SS, Link MP, Weinstein HJ, et al.: Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin\u2019s disease. J Clin Oncol 2007, 25:332\u2013337.","journal-title":"J Clin Oncol"},{"key":"20_CR49","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1200\/JCO.2006.05.6879","volume":"24","author":"L.M. Chow","year":"2006","unstructured":"Chow LM, Nathan PC, Hodgson DC, et al.: Survival and late effects in children with Hodgkin\u2019s lymphoma treated with MOPP\/ABV and low-dose, extended-field irradiation. J Clin Oncol 2006, 24:5735\u20135741.","journal-title":"J Clin Oncol"},{"key":"20_CR50","unstructured":"Children\u2019s Oncology Group: Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers (Ver. 2.0, 2006). http:\/\/www.survivorshipguidelines.org\/ . Accessed March 2007."},{"key":"20_CR51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","volume":"57","author":"D. Saslow","year":"2007","unstructured":"Saslow D, Boetes C, Burke W, et al.: American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007, 57:75\u201389.","journal-title":"CA Cancer J Clin"},{"key":"20_CR52","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Expert Panel on Detection EvaluationTreatment of High Blood Cholesterol In Adults","year":"2001","unstructured":"Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol In Adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285:2486\u20132497.","journal-title":"JAMA"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-007-0020-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11899-007-0020-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-007-0020-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:08:10Z","timestamp":1559419690000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11899-007-0020-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,27]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["20"],"URL":"https:\/\/doi.org\/10.1007\/s11899-007-0020-4","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,27]]}}}